ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 175 filers reported holding ANTARES PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $51,000 | -16.4% | 14,000 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $61,000 | +5.2% | 14,000 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $58,000 | +3.6% | 14,000 | 0.0% | 0.01% | -27.3% |
| Q4 2020 | $56,000 | +47.4% | 14,000 | 0.0% | 0.01% | +37.5% |
| Q3 2020 | $38,000 | -2.6% | 14,000 | 0.0% | 0.01% | -11.1% |
| Q2 2020 | $39,000 | +18.2% | 14,000 | 0.0% | 0.01% | +12.5% |
| Q1 2020 | $33,000 | -50.0% | 14,000 | 0.0% | 0.01% | -38.5% |
| Q4 2019 | $66,000 | +40.4% | 14,000 | 0.0% | 0.01% | +30.0% |
| Q3 2019 | $47,000 | +2.2% | 14,000 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $46,000 | +9.5% | 14,000 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $42,000 | +10.5% | 14,000 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $38,000 | -19.1% | 14,000 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $47,000 | – | 14,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,055,000 | 4.58% |
| Centric Wealth Management | 3,337,449 | $13,717,000 | 3.92% |
| Sargent Investment Group, LLC | 3,599,580 | $14,794,000 | 3.90% |
| Rubric Capital Management LP | 8,722,647 | $35,850,000 | 2.09% |
| PERKINS CAPITAL MANAGEMENT INC | 542,283 | $2,229,000 | 1.29% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $7,809,000 | 1.17% |
| Venator Capital Management Ltd. | 550,000 | $2,624,000 | 0.89% |
| LEVEL FOUR FINANCIAL, LLC | 120,000 | $493,000 | 0.23% |
| ALGERT GLOBAL LLC | 147,616 | $607,000 | 0.19% |
| Brown Advisory Securities, LLC | 275,000 | $1,130,000 | 0.19% |